Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of 225Ac-PSMA (Prostate-Specific Membrane Antigen)

Added 566 days ago (05.11.2020)
Authors: Maria Luisa Belli; Anna Sarnelli; Emilio Mezzenga; Francesco Cesarini; Paola Caroli; Valentina Di Iorio; Lidia Strigari; Marta Cremonesi; Antonino Romeo; Silvia Nicolini; Federica Matteucci; Stefano Severi; Giovanni Paganelli
Read article